Androgens protect against apolipoprotein E4-induced cognitive deficits

Area of Science:

• Neuroscience
• Genetics
• Endocrinology

Background:

• Apolipoprotein E4 (apoE4) is a significant genetic risk factor for Alzheimer's disease (AD).
• The interaction between apoE4 and female sex exacerbates AD risk and diminishes treatment efficacy.
• Sex differences in susceptibility to apoE4-induced cognitive impairments are observed, with females being more vulnerable.

Purpose of the Study:

• To investigate the role of sex steroids in apoE4-mediated cognitive decline.
• To determine if androgen stimulation can ameliorate apoE4-associated memory deficits.
• To explore the relationship between androgen receptor (AR) levels and cognitive function in apoE4-expressing mice.

Main Methods:

• Utilized genetically modified mice expressing human apoE4 or apoE3 in an apoE-deficient background.
• Administered androgen treatment and androgen receptor blockers to assess effects on spatial learning and memory.
• Quantified cytosolic androgen receptor levels in the neocortex.

Main Results:

• Androgen treatment significantly improved memory deficits in female apoE4 mice, an effect not seen in female apoE3 mice.
• Blockade of androgen receptors induced spatial learning and memory deficits in male apoE4 mice, but not in male apoE3 mice.
• ApoE4 mice exhibited lower baseline cytosolic AR levels in the neocortex compared to controls, which increased with beneficial androgen treatment.

Conclusions:

• Apolipoprotein E4 contributes to cognitive decline by reducing brain androgen receptor levels.
• Stimulating androgen receptor-dependent pathways offers a potential therapeutic strategy to reverse apoE4-induced cognitive deficits.
• Sex hormones play a critical role in modulating the impact of apoE4 on cognitive function.